Skip to content
naulon
Not checkedNot checked for notices yet.

Diagnostic potential of the amniotic fluid cells transcriptome in deciphering mendelian disease: a proof-of-concept

Mianne Lee, Anna K. Y. Kwong, Martin M. C. Chui and 9 more

npj Genomic Medicine · 2022

doi:10.1038/s41525-022-00347-4 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

RNA sequencing (RNA-seq) is emerging in genetic diagnoses as it provides functional support for the interpretation of variants of uncertain significance. However, the use of amniotic fluid (AF) cells for RNA-seq has not yet been explored. Here, we examined the expression of clinically relevant genes in AF cells ( n = 48) compared with whole blood and fibroblasts. The number of well-expressed genes in AF cells was comparable to that in fibroblasts and much higher than that in blood across different disease categories. We found AF cells RNA-seq feasible and beneficial in prenatal diagnosis ( n = 4) as transcriptomic data elucidated the molecular consequence leading to the pathogenicity upgrade of variants in CHD7 and COL1A2 and revising the in silico prediction of a variant in MYRF . AF cells RNA-seq could become a reasonable choice for postnatal patients with advantages over fibroblasts and blood as it prevents invasive procedures.

Abstract licence: CC BY-NC-ND

References74

  1. 12.
  2. 20.
  3. 24.
  4. 26.
  5. 28.
  6. 31.
  7. 33.
  8. 35.
  9. 40.

31 more references, whose wording the paper’s licence keeps private.

All 74 references

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.